Brain Bleed Survivors Walk a Razor-Thin Line Taking DOACs

MedPage Today) — LOS ANGELES — In the PRESTIGE-AF trial, survivors of intracerebral hemorrhage (ICH) had good protection against future ischemic events using direct oral anticoagulants (DOACs) — though, as feared, bleeding side effects…
Read More